Study Identifies Factors That Predict Driving Cessation in Seniors
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 22, 2024 -- Among older adults, factors associated with future driving cessation include female sex and neuropsychological measures of cognitive functioning, according to a study published online May 22 in Neurology.
Ganesh M. Babulal, Ph.D., from the Washington University School of Medicine in St. Louis, and colleagues conducted a prospective, longitudinal observation study involving participants from the Knight Alzheimer Disease Research Center and The DRIVES Project. Participants were aged 65 years or older, drove weekly, and were cognitively normal at baseline. A total of 283 participants were included in the study and were followed for a mean of 5.62 years.
The researchers found associations for driving cessation with older age, female sex, progression to symptomatic Alzheimer disease (Clinical Dementia Rating [CDR] ≥0.5), and poorer performance on a preclinical Alzheimer cognitive composite (PACC) score. Driving cessation was not independently predicted by beta-amyloid (Aβ) positron emission tomography imaging, but cerebrospinal fluid biomarkers, specifically t-Tau/Aβ42 and p-Tau/Aβ42 ratios were independent predictors in a simple model adjusting for age, education, and sex. Progression to cognitive impairment based on the CDR and PACC score was associated with a higher risk for driving cessation in the full model, but Alzheimer disease biomarkers were not statistically significant.
"This research contributes valuable insights into the predictors of driving cessation in older adults, with implications for clinical practice and public health policy," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.